Jen Rowland

Jen Rowland has a strong background in the pharmaceutical industry with experience spanning over 20 years. Jen currently serves as the Director of Marketing for Fetroja at Shionogi Inc. Prior to this, they held various roles at Merck, including Associate Director of Marketing for US Surgery & Anesthesia, Associate Director of Institutional Antibiotic Sales, and Executive Institutional Representative. Jen also worked as a Clinical Business Manager at Cubist Pharmaceuticals before it was acquired by Merck. Additionally, they have held positions at Lumara Health, Teva Pharmaceuticals, Schering Pharmaceuticals, Novartis, and Forest Pharmaceuticals, where they gained experience in sales and account management.

Jen Rowland has a Bachelor's Degree from Florida Gulf Coast University. Jen also attended the University of Central Florida, although no specific degree or field of study was mentioned. Currently, they are enrolled in the Women's Leadership Program at Cornell University, pursuing a Professional Certificate, which is expected to be completed in 2021.